Clinical Trials Sponsored by Sun Yat-sen University

Total 8248 results

Sun Yat-sen University

Active, not recruiting

Study of Nivolumab for Non-Small Cell Lung Cancer (Stage III) Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation Therapy

Stage III Non-small-cell Lung Cancer

China
Sun Yat-sen University

Completed

Metronomic Chemotherapy in a Real-world Population of Advanced Breast Cancer Patients

Breast Cancer

China
Sun Yat-sen University

Completed

The Risk Assessment Scale for Peripherally Inserted Central Venous Catheter (PICC) Related Thrombosis in Cancer Patients

Thrombosis | Catheter

China
Sun Yat-sen University

Completed

Characteristics and Tumor Staging Proposal for Primary Malignant Melanoma of the Esophagus

Primary Malignant Melanoma of the Esophagus

China
Sun Yat-sen University

Active, not recruiting

Metronomic Capecitabine Plus Aromatase Inhibitor for First Line Treatment in HR(+), Her2(-) Metastatic Breast Cancer (MECCA)

Breast Cancer

China
Sun Yat-sen University

Active, not recruiting

Toripalimab Plus Neoadjuvant Chemotherapy Combined With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma

China
Sun Yat-sen University

Completed

Atezolizumab Plus Bevacizumab Versus Sintilimab Plus Bevacizumab With TACE and HAIC in Unresectable Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Sun Yat-sen University

Completed

A Conversational AI System to Enhance Knowledge About Vaccines and Promote Vaccination

Vaccination Hesitancy

China
Sun Yat-sen University

Completed

Efficacy of Using Large Language Model to Assist in Diabetic Retinopathy Detection

Diabetic Retinopathy | Diagnosis

China
Sun Yat-sen University

Active, not recruiting

Study of Porcine Fibrin Sealant in Preventing Cervical Anastomotic Leakage (PLACE030)

Esophageal Anastomotic Leak

China
Sun Yat-sen University

Active, not recruiting

SBRT Followed by Neoadjuvant Immunochemotherapy in Resectable Stage II to III Non-small Cell Lung Cancer (SACTION01)

Carcinoma, Non-Small-Cell Lung

China
Sun Yat-sen University

Active, not recruiting

A Study of Cadonilimab Combined With Regorafenib in Patients With Advanced HCC

Advanced Hepatocellular Carcinoma

China
Sun Yat-sen University

Completed

Study of Early Nutritional Intervention During Concurrent Chemoradiotherapy for Local Advanced Non-small Cell Lung Cancer

Local Advanced Non-small Cell Lung Cancer

China
Sun Yat-sen University

Active, not recruiting

The Role of Induction Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma in the Era of IMRT

Nasopharyngeal Carcinoma

China
Sun Yat-sen University

Enrolling by invitation

Chemotherapy Combined With High-dose Radiotherapy for Low Rectal Cancer Using MR Guided Linear Accelerator

Rectal Cancer

China
Sun Yat-sen University

Completed

Exploring the Influence of Clinical Factors on the Prognosis of Papillary Renal Cell Carcinoma

Carcinoma, Renal Cell
Sun Yat-sen University

Active, not recruiting

TNT to Increase the Clinical Complete Response Rate for Distal LARC (TESS)

Chemoradiation | Rectal Cancer | Rectal Cancer Stage II | Rectal Cancer Stage III

China
Sun Yat-sen University

Active, not recruiting

Follow-up Strategy for Esophageal Cancer Patients

Esophagus Cancer

China
Sun Yat-sen University

Completed

Bevacizumab Combined With Fractionated Stereotactic Radiotherapy for 1 to 10 Brain Metastases From NSCLC

Non-small Cell Lung Cancer

China
Sun Yat-sen University

Completed

Vitamin C Intravenously With Chemotherapy in Advanced Colorectal Cancer (Vitality)

Colorectal Neoplasms

China
Sun Yat-sen University

Active, not recruiting

Nab-paclitaxel Based TPX Neoadjuvant Chemotherapy for NPC Patients: a Dose-escalation Study

Nasopharyngeal Cancer

China
Sun Yat-sen University

Active, not recruiting

Microvascular Invasion for Guiding Treatment of Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma

Hepatocellular Carcinoma (HCC) | Radiomics | Transcatheter Arterial Chemoembolization (TACE) | Microvascular Invasion (MVI) | Multi-kinase Inhibitors (MKI)

China
Sun Yat-sen University

Completed

Tislelizumab Combined With Pemetrexed/ Carboplatin in Patients With Brain Metastases of Non-squamous NSCLC

Brain Metastases | NSCLC Stage IV | PD-1 Antibody

China
Sun Yat-sen University

Completed

High Dose Radiotherapy for the Treatment of Rectal Cancer

Rectal Cancer

China
Sun Yat-sen University

Completed

TPC vs PF as Induction Chemotherapy Combined With CCRT for Stage IVa-b Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Sun Yat-sen University

Completed

SHR-1210 in Combination With Apatinib in Patients With Metastatic, Persistent, or Recurrent Cervical Cancer

Recurrent Cervical Carcinoma | Metastatic Cervical Cancer

China
Sun Yat-sen University

Completed

Bevacizumab After Chemoradiotherapy For Locally Advanced Lung Adenocarcinoma

Lung Adenocarcinoma

China
Sun Yat-sen University

Terminated

FUDR/Oxaliplatin HAI Plus Irinotecan vs. FOLFOXIRI Chemotherapy in Treating Initially Unresectable CRCLM

Metastatic Colorectal Cancer | Liver Metastases

China
Sun Yat-sen University

Active, not recruiting

Toripalimab and Gemcitabine in Recurrent or Metastatic Nasopharyngeal Carcinoma.

Nasopharyngeal Carcinoma | Chemotherapy Effect | Immunotherapy | Recurrent Nasopharyngeal Carcinoma | Metastatic Nasopharyngeal Carcinoma

China
Sun Yat-sen University

Completed

Tumor Budding in Patients With Colorectal Cancer Under Different MMR Status

Rectal Cancer | Tumor Budding

China
Sun Yat-sen University

Completed

PD-1 Antibody in EBV Positive Metastatic Gastric Cancer Patients.

Gastric Cancer Stage IV | EBV

China
Sun Yat-sen University

Completed

Surgery Alone Versus Neoadjuvant Treatment Followed by Surgery For MRI-defined T3 Mid-low Rectal Cancer

Rectal Cancer
Sun Yat-sen University

Completed

TIP (Paclitaxel + Ifosfamide + Cisplatin) Combined With Nimotuzumab & Triprilimab as Neoadjuvant Treatment in Locally Advanced Penile Cancer

Penile Cancer

China
Sun Yat-sen University

Completed

Combined Treatment of Sintilimab, Peg-aspargase Plus Anlotinib in NK/T Cell Lymphoma

Radiotherapy | Sintilimab | Anlotinib | Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type | Early Stage | Peg-aspargase | Phase Two | Open

China
Sun Yat-sen University

Active, not recruiting

Effect of Probiotics on Lipid Management

Primary Hypercholesterolemia

China
Sun Yat-sen University

Completed

Effect of Probiotics on Cardiometabolic Health

Cardiometabolic Risk Factors

China
Sun Yat-sen University

Active, not recruiting

Effect of Prebiotics on Blood Glucose Management

Hyperglycemia | Insulin Sensitivity

China
Sun Yat-sen University

Active, not recruiting

Gemcitabine Combined With Apatinib and Toripalimab in Recurrent or Metastatic Nasopharyngeal Carcinoma.

Nasopharyngeal Carcinoma

China
Sun Yat-sen University

Active, not recruiting

Evaluation of MBL Around Implants Placed in Crestal or Subcrestal Positions: a RCT

Partial Edentulism | Jaw, Edentulous

China
Sun Yat-sen University

Completed

Efficacy of High Dose Tamoxifen to Advanced Hormone Receptor-High Expressed Breast Cancer

Breast Cancer Metastatic

China
Sun Yat-sen University

Completed

Intelligent Evaluation and Supervision of Cataract Surgery

Cataract

China
Sun Yat-sen University

Completed

Visual Function in Pediatric Patients With Posterior Lens Opacities

Congenital Cataract Polar Posterior

China
Sun Yat-sen University

Completed

Study of Thymosin α1 to Reduce Acute Pneumonia For Bulky None-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Sun Yat-sen University

Withdrawn

Post-operative Satisfaction With Glaucoma Surgery Trial

Glaucoma

China
Sun Yat-sen University

Enrolling by invitation

Mutation Detection for VRL

Uveitis | Vitreoretinal Lymphoma

China
Sun Yat-sen University

Withdrawn

Satisfaction After Glaucoma Surgery in Rural China

Glaucoma

China
Sun Yat-sen University

Completed

Optimal Treatment on Hepatocellular Carcinoma (HCC) With Cirrhotic Portal Hypertension

Hepatocellular Carcinoma(HCC) | Cirrhotic Portal Hypertension

China
Sun Yat-sen University

Completed

uEXPLORER Total-body PET/CT in Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Sun Yat-sen University

Completed

The Efficacy and Safety of Thymosin-α1 in Patients With HBV-related ACLF

Liver Failure

China
Sun Yat-sen University

Completed

ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage II to IIIA NSCLC by NGS

NSCLC

China

3

Subscribe